Literature DB >> 903770

Axonal dysfunction in the neuropathy of diabetes mellitus: a quantitative electrophysiological study.

S Hansen, J P Ballantyne.   

Abstract

The extent of axonal dysfunction in a group of patients with diabetes mellitus has been investigated using recently introduced quantitative techniques of electromyography. In 40 diabetic patients, estimates of motor unit numbers in the extensor digitorum brevis muscles and measurements of the parameters of electrically evoked motor unit potentials therein are presented, along with significant correlations between these parameters and motor nerve conduction velocities and distal motor latencies in the lateral popliteal nerves. The results indicate that axonal dysfunction and concomitant collateral reinnervation are prominent and integral features of the neuropathy of diabetes mellitus. Axonal dysfunction is present in proportion to and parallels the severity of the demyelinative lesion. It is also extensive in patients without clinical evidence of neuropathy in whom the accompanying collateral reinnervation is of sufficient magnitude to mask the clinical signs of motor involvement.

Entities:  

Mesh:

Year:  1977        PMID: 903770      PMCID: PMC492761          DOI: 10.1136/jnnp.40.6.555

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  CHANGES IN NERVE CONDUCTION IN EXPERIMENTAL ALLERGIC NEURITIS.

Authors:  B G CRAGG; P K THOMAS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

2.  THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN PERIPHERAL NERVE: A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. II. ELECTROPHYSIOLOGICAL OBSERVATIONS.

Authors:  W I MCDONALD
Journal:  Brain       Date:  1963-09       Impact factor: 13.501

3.  The morbid anatomy of diabetic neuropathy.

Authors:  C L DOLMAN
Journal:  Neurology       Date:  1963-02       Impact factor: 9.910

4.  Peripheral nerve conduction in diabetic neuropathy.

Authors:  R W GILLIATT; R G WILLISON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-02       Impact factor: 10.154

5.  A quantitative electrophysiological study of acute idiopathic polyneuritis.

Authors:  A Martinez-Figueroa; S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

6.  Nerve impulses and trophic effect. Absence of fibrillation after prolonged and reversible conduction block.

Authors:  E D Robert; Y T Oester
Journal:  Arch Neurol       Date:  1970-01

7.  Computer method for the analysis of evoked motor unit potentials. I. Control subjects and patients with myasthenia gravis.

Authors:  J P Ballantyne; S Hansen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-11       Impact factor: 10.154

8.  The pathogenesis of sural nerve changes in diabetes mellitus.

Authors:  J S Chopra; L J Hurwitz; D A Montgomery
Journal:  Brain       Date:  1969       Impact factor: 13.501

9.  Computer method for the analysis of evoked motor unit potentials. 2. Duchenne, limb-girdle, facioscapulohumeral and myotonic muscular dystrophies.

Authors:  J P Ballantyne; S Hansen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-05       Impact factor: 10.154

10.  The neuropathies associated with diabetes mellitus. A clinical and electromyographic study of 103 unselected diabetic patients.

Authors:  D W MULDER; E H LAMBERT; J A BASTRON; R G SPRAGUE
Journal:  Neurology       Date:  1961-04       Impact factor: 9.910

View more
  15 in total

1.  Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure.

Authors:  Matti D Allen; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

2.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy.

Authors:  Matti D Allen; Brendan Major; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

4.  Motor unit potential abnormalities in multiple sclerosis: further evidence for a peripheral nervous system defect.

Authors:  A I Weir; S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

5.  A quantitative electrophysiological study of motor neurone disease.

Authors:  S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

6.  Structural relationships between the endogenous volatile urinary metabolites of experimentally diabetic rats and certain neurotoxins (l).

Authors:  G Rhodes; M L Holland; D Wiesler; M Novotny; S A Moore; R G Peterson; D L Felten
Journal:  Experientia       Date:  1982-01-15

7.  A quantitative electrophysiological study of uraemic neuropathy. Diabetic and renal neuropathies compared.

Authors:  S Hansen; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

Review 8.  Physiology in Medicine: neuromuscular consequences of diabetic neuropathy.

Authors:  Matti D Allen; Timothy J Doherty; Charles L Rice; Kurt Kimpinski
Journal:  J Appl Physiol (1985)       Date:  2016-03-17

Review 9.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Motor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes.

Authors:  Nizar Souayah; Joseph G Potian; Carmen C Garcia; Natalia Krivitskaya; Christine Boone; Vanessa H Routh; Joseph J McArdle
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.